e-Therapeutics to join AIM

Newcastle-based e-Therapeutics plans to join London’s Alternative Investment Market in the near future. The drug discovery company owns candidate drugs in five therapeutic areas, which together represent a potential market of more than $80bn.

Leave a Reply